INTT vs. AEHR, QTRX, QSI, NAUT, KEQU, FEIM, SEER, RPID, AKYA, and MASS
Should you be buying inTEST stock or one of its competitors? The main competitors of inTEST include Aehr Test Systems (AEHR), Quanterix (QTRX), Quantum-Si (QSI), Nautilus Biotechnology (NAUT), Kewaunee Scientific (KEQU), Frequency Electronics (FEIM), Seer (SEER), Rapid Micro Biosystems (RPID), Akoya Biosciences (AKYA), and 908 Devices (MASS). These companies are all part of the "measuring and control equipment" industry.
inTEST vs.
Aehr Test Systems (NASDAQ:AEHR) and inTEST (NYSE:INTT) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, community ranking, risk, valuation, profitability, dividends, analyst recommendations, media sentiment and institutional ownership.
Aehr Test Systems received 121 more outperform votes than inTEST when rated by MarketBeat users. Likewise, 58.15% of users gave Aehr Test Systems an outperform vote while only 57.89% of users gave inTEST an outperform vote.
Aehr Test Systems has higher earnings, but lower revenue than inTEST. Aehr Test Systems is trading at a lower price-to-earnings ratio than inTEST, indicating that it is currently the more affordable of the two stocks.
Aehr Test Systems has a net margin of 43.41% compared to inTEST's net margin of 2.33%. Aehr Test Systems' return on equity of 21.09% beat inTEST's return on equity.
69.7% of Aehr Test Systems shares are held by institutional investors. Comparatively, 63.2% of inTEST shares are held by institutional investors. 6.2% of Aehr Test Systems shares are held by insiders. Comparatively, 5.5% of inTEST shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
In the previous week, Aehr Test Systems had 5 more articles in the media than inTEST. MarketBeat recorded 6 mentions for Aehr Test Systems and 1 mentions for inTEST. Aehr Test Systems' average media sentiment score of 0.73 beat inTEST's score of 0.00 indicating that Aehr Test Systems is being referred to more favorably in the media.
Aehr Test Systems has a beta of 1.81, meaning that its share price is 81% more volatile than the S&P 500. Comparatively, inTEST has a beta of 1.84, meaning that its share price is 84% more volatile than the S&P 500.
Aehr Test Systems presently has a consensus target price of $25.00, indicating a potential upside of 118.72%. inTEST has a consensus target price of $16.00, indicating a potential upside of 86.92%. Given Aehr Test Systems' higher possible upside, equities research analysts clearly believe Aehr Test Systems is more favorable than inTEST.
Summary
Aehr Test Systems beats inTEST on 13 of the 19 factors compared between the two stocks.
Get inTEST News Delivered to You Automatically
Sign up to receive the latest news and ratings for INTT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools
This page (NYSE:INTT) was last updated on 2/22/2025 by MarketBeat.com Staff